Novozymes BioAg offers plant health solutions to farmers, and they'll be engaging in the animal health space after acquiring Chr. Hansen. Director of Sales Jason Ward says biologics are gaining momentum in the marketplace. The products are not 'new', but more companies are entering the space, creating more buzz around natural plant health products. While the news of Novozymes' acquisition of Chr. Hansen has been out for about a year, the timeline for when the two companies combine is a moving target. Currently, they anticipate the first quarter of 2024.